Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Ivo G Schoots

Showing results (1-10 of 171) with videos related to

Pageof 18
Sort By:
Annals of Translational Medicine|June 14, 2016
Omission of systematic transrectal ultrasound guided biopsy from the MRI targeted approach in men with previous negative prostate biopsy might still be prematureIvo G Schoots
Translational Andrology and Urology|March 30, 2018
MRI in early prostate cancer detection: how to manage indeterminate or equivocal PI-RADS 3 lesions?Ivo G Schoots
BMJ Evidence-Based Medicine|October 26, 2018
MRI and MRI-targeted biopsy take precedence over systematic biopsy in primary prostate cancer diagnosisIvo G Schoots, Olivier Rouvière
Abdominal Radiology (New York)|May 2, 2020
Delivering Clinical impacts of the MRI diagnostic pathway in prostate cancer diagnosisIvo G Schoots, Anwar R Padhani
Translational Andrology and Urology|July 21, 2017
From PROMIS to PRO-MRI in primary prostate cancer diagnosisIvo G Schoots, Monique J Roobol
European Urology Open Science|March 4, 2022
Magnetic Resonance Imaging-based Monitoring in Active Surveillance: Are We Ready To Jump on the Bandwagon?Chris H Bangma, Ivo G Schoots
World Journal of Urology|August 11, 2019
Personalizing prostate cancer diagnosis with multivariate risk prediction tools: how should prostate MRI be incorporated?Ivo G Schoots, Anwar R Padhani
European Radiology|May 8, 2023
Prostate cancer screening-stepping forward with MRIAnwar R Padhani, Ivo G Schoots
World Journal of Urology|March 15, 2019
Multivariate risk prediction tools including MRI for individualized biopsy decision in prostate cancer diagnosis: current status and future directionsIvo G Schoots, Monique J Roobol
BJU International|October 22, 2020
Risk-adapted biopsy decision based on prostate magnetic resonance imaging and prostate-specific antigen density for enhanced biopsy avoidance in first prostate cancer diagnostic evaluationIvo G Schoots, Anwar R Padhani
Pageof 18

Showing results (1-10 of 171) with videos related to

Sort By:
Pageof 18
Annals of Translational Medicine|June 14, 2016
Omission of systematic transrectal ultrasound guided biopsy from the MRI targeted approach in men with previous negative prostate biopsy might still be prematureIvo G Schoots
Translational Andrology and Urology|March 30, 2018
MRI in early prostate cancer detection: how to manage indeterminate or equivocal PI-RADS 3 lesions?Ivo G Schoots
BMJ Evidence-Based Medicine|October 26, 2018
MRI and MRI-targeted biopsy take precedence over systematic biopsy in primary prostate cancer diagnosisIvo G Schoots, Olivier Rouvière
Abdominal Radiology (New York)|May 2, 2020
Delivering Clinical impacts of the MRI diagnostic pathway in prostate cancer diagnosisIvo G Schoots, Anwar R Padhani
Translational Andrology and Urology|July 21, 2017
From PROMIS to PRO-MRI in primary prostate cancer diagnosisIvo G Schoots, Monique J Roobol
European Urology Open Science|March 4, 2022
Magnetic Resonance Imaging-based Monitoring in Active Surveillance: Are We Ready To Jump on the Bandwagon?Chris H Bangma, Ivo G Schoots
World Journal of Urology|August 11, 2019
Personalizing prostate cancer diagnosis with multivariate risk prediction tools: how should prostate MRI be incorporated?Ivo G Schoots, Anwar R Padhani
European Radiology|May 8, 2023
Prostate cancer screening-stepping forward with MRIAnwar R Padhani, Ivo G Schoots
World Journal of Urology|March 15, 2019
Multivariate risk prediction tools including MRI for individualized biopsy decision in prostate cancer diagnosis: current status and future directionsIvo G Schoots, Monique J Roobol
BJU International|October 22, 2020
Risk-adapted biopsy decision based on prostate magnetic resonance imaging and prostate-specific antigen density for enhanced biopsy avoidance in first prostate cancer diagnostic evaluationIvo G Schoots, Anwar R Padhani
Pageof 18